tiprankstipranks
Positive Outlook on VYNE Therapeutics Driven by Promising VYN202 Developments and Selective BD2 Targeting
PremiumRatingsPositive Outlook on VYNE Therapeutics Driven by Promising VYN202 Developments and Selective BD2 Targeting
1M ago
VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment
Premium
Ratings
VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment
1M ago
VYNE Therapeutics announces dosing of first patient in Phase 1b trial of VYN202
Premium
The Fly
VYNE Therapeutics announces dosing of first patient in Phase 1b trial of VYN202
1M ago
VYNE Therapeutics initiated with a Buy at BTIG on I&I potential
PremiumThe FlyVYNE Therapeutics initiated with a Buy at BTIG on I&I potential
4M ago
VYNE Therapeutics initiated with a Buy at BTIG
Premium
The Fly
VYNE Therapeutics initiated with a Buy at BTIG
4M ago
VYNE Therapeutics Advances Clinical Pipeline in Q3 2024
Premium
Company Announcements
VYNE Therapeutics Advances Clinical Pipeline in Q3 2024
5M ago
Vyne Therapeutics Inc (VYNE) Q2 Earnings Cheat Sheet
PremiumPre-EarningsVyne Therapeutics Inc (VYNE) Q2 Earnings Cheat Sheet
8M ago
VYNE Therapeutics announces granting of composition of matter patent for VYN202
Premium
The Fly
VYNE Therapeutics announces granting of composition of matter patent for VYN202
9M ago
VYNE Therapeutics announces appointment of Banerjee as SVP
Premium
The Fly
VYNE Therapeutics announces appointment of Banerjee as SVP
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100